Rare Cannabinoid Company Publishes Guide on CBD, THC, CBN Use During Menopause

Rare Cannabinoid Company has published a comprehensive guide examining the use of CBD, THC, CBN, and other hemp-derived cannabinoids during menopause. The guide aims to clarify how different cannabinoids may support sleep quality, mood, and general well-being in midlife.

As an increasing number of women seek information about cannabis and hemp-derived cannabinoids during perimenopause and menopause, the company's new guide, "CBD for Menopause: A Guide to Cannabis, THC, CBN and Hemp," delves into the growing interest in CBD for alleviating menopausal symptoms such as sleep disturbances, mood swings, and physical discomfort.

The guide explains the emerging research and the distinctions between various cannabinoids, emphasizing that CBD, THC, and CBN are not interchangeable. CBD (cannabidiol) is described as non-intoxicating and supportive of calmness. CBN (cannabinol) is associated with nighttime relaxation, while THC (tetrahydrocannabinol) may offer deeper relaxation but comes with individual sensitivities and legal considerations.

Furthermore, the guide introduces other cannabinoids like CBG (cannabigerol), often used for physical relief, CBC (cannabichromene) for mood support, THCV (tetrahydrocannabivarin) for energy and focus, and the rare CBDV (cannabidivarin) for enhanced social ease and reduced irritability. The company stresses the need for balanced and practical information without promising miracle cures.

According to the company, the guide is designed to help women better understand the potential and limitations of cannabinoids as part of their personal wellness routines during menopause. It also compares different cannabinoid products, including gummies, oils, and topical applications.